The Effect of Linagliptin on Mitochondrial and Endothelial Function

NCT01969084 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: Linagliptin
DRUG: Placebo
OTHER: Microcirculation testing
OTHER: Macrocirculation testing
OTHER: MRI Scans

Sponsor

Beth Israel Deaconess Medical Center